229 related articles for article (PubMed ID: 33644851)
21. Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E.
Tzeng CM; Adams EJ; Gumperz JE; Percival L; Wells RS; Parham P; Barber LD
Tissue Antigens; 1996 Oct; 48(4 Pt 1):325-8. PubMed ID: 8946687
[TBL] [Abstract][Full Text] [Related]
22. Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.
Berkers CR; de Jong A; Schuurman KG; Linnemann C; Meiring HD; Janssen L; Neefjes JJ; Schumacher TN; Rodenko B; Ovaa H
J Immunol; 2015 Nov; 195(9):4085-95. PubMed ID: 26401003
[TBL] [Abstract][Full Text] [Related]
23. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.
Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M
J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands.
Perez MAS; Bassani-Sternberg M; Coukos G; Gfeller D; Zoete V
Front Immunol; 2019; 10():2731. PubMed ID: 31824508
[TBL] [Abstract][Full Text] [Related]
25. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation.
Goncalves G; Mullan KA; Duscharla D; Ayala R; Croft NP; Faridi P; Purcell AW
Front Immunol; 2021; 12():645770. PubMed ID: 33968037
[TBL] [Abstract][Full Text] [Related]
26. Immunology: keeping mother at bay.
Parham P
Curr Biol; 1996 Jun; 6(6):638-41. PubMed ID: 8793281
[TBL] [Abstract][Full Text] [Related]
27. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
[TBL] [Abstract][Full Text] [Related]
28. Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference.
Marino F; Semilietof A; Michaux J; Pak HS; Coukos G; Müller M; Bassani-Sternberg M
Front Immunol; 2020; 11():1981. PubMed ID: 32983136
[TBL] [Abstract][Full Text] [Related]
29. High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells.
Jarmalavicius S; Welte Y; Walden P
J Biol Chem; 2012 Sep; 287(40):33401-11. PubMed ID: 22869377
[TBL] [Abstract][Full Text] [Related]
30. The impact of immunopeptidomics: From basic research to clinical implementation.
Shapiro IE; Bassani-Sternberg M
Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
[TBL] [Abstract][Full Text] [Related]
31. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
32. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
[TBL] [Abstract][Full Text] [Related]
33. Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
Zhang Q; Liu K; Yue C; Zhang D; Lu D; Xiao W; Liu P; Zhao Y; Gao G; Ding C; Lyu J; Liu WJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522857
[TBL] [Abstract][Full Text] [Related]
34. MHC class I associations beyond HLA-B27: the peptide binding hypothesis of psoriatic arthritis and its implications for disease pathogenesis.
Winchester R; FitzGerald O
Curr Opin Rheumatol; 2020 Jul; 32(4):330-336. PubMed ID: 32412996
[TBL] [Abstract][Full Text] [Related]
35. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
36. Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.
Doolan DL; Wizel B; Hoffman SL
Immunol Res; 1996; 15(4):280-305. PubMed ID: 8988396
[TBL] [Abstract][Full Text] [Related]
37. The induction of tolerance to alloantigens using HLA-based synthetic peptides.
Krensky AM; Clayberger C
Curr Opin Immunol; 1994 Oct; 6(5):791-6. PubMed ID: 7826536
[TBL] [Abstract][Full Text] [Related]
38. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
39. Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.
Wilhelm M; Zolg DP; Graber M; Gessulat S; Schmidt T; Schnatbaum K; Schwencke-Westphal C; Seifert P; de Andrade Krätzig N; Zerweck J; Knaute T; Bräunlein E; Samaras P; Lautenbacher L; Klaeger S; Wenschuh H; Rad R; Delanghe B; Huhmer A; Carr SA; Clauser KR; Krackhardt AM; Reimer U; Kuster B
Nat Commun; 2021 Jun; 12(1):3346. PubMed ID: 34099720
[TBL] [Abstract][Full Text] [Related]
40. Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing.
Paes W; Leonov G; Partridge T; Nicastri A; Ternette N; Borrow P
Front Immunol; 2020; 11():563800. PubMed ID: 33072102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
